Stockscreener 앱 받기
72.57
0.07%
0.05
Bio Techne Corp 주식(TECH)의 최신 뉴스
Bio-Techne Expands Global GMP Manufacturing Network with New Bristol Facility to Advance Scalable Cell Therapy Development - Investing News Network
Bio-Techne Expands Global GMP Manufacturing Network with New Bristol Facility to Advance Scalable Cell Therapy Development - Yahoo Finance
Bio-Techne Company Profile & Introduction - Moomoo
INCY or TECH: Which Is the Better Value Stock Right Now? - Zacks Investment Research
Robert V Baumgartner Exercises Options, Realizes $754KBio-Techne (NASDAQ:TECH) - Benzinga
Bio-Techne (TECH) Shareholders Approve the Merck KGaA Takeover and Reject the Pay Package - Yahoo Finance
Bio-Techne (TECH) director exercises options and delivers or withholds 5,559 shares for costs or taxes. - Stock Titan
Bio-Techne shareholders approve $11.3 billion merger with German Merck - AKM.RU
What Does Shareholder Approval Mean for Bio-Techne's (NASDAQ:TECH) Merck KGaA Deal? - Kalkine Media
Is Bio-Techne Stock Outperforming the Nasdaq? - finance.yahoo.com
Is Bio-Techne Stock Outperforming the Nasdaq? - barchart.com
Form 8K Bio-Techne Corp For: 23 September By Investing.com - Investing.com Canada
Form 8K Bio-Techne Corp For: 23 September - Investing.com India
Merck KGaA's USD 11.3b Bio-Techne acquisition clears final shareholder approval hurdle - AllSci
Bio-Techne (TECH) Opens Düsseldorf Hub As Fair Value Questions Come Into Focus - simplywall.st
Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany - Investing News Network
Bio-Techne shareholders approve Merck KGaA acquisition - Investing.com
Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany - PR Newswire
Bio-Techne Opens New Customer Experience Center in Germany - marketscreener.com
Bio-Techne Opens New Customer Experience Center in Germany - finance.yahoo.com
Bio-Techne opens customer experience center in Düsseldorf - Investing.com
Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer Collaboration - marketscreener.com
Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer Collaboration - Yahoo Finance
Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer Collaboration - Investing News Network
Bio-Techne Corp (TECH) Investor Outlook: Navigating Market Dynamics with a Focus on Growth Potential - DirectorsTalk Interviews
Why Is Techne (TECH) Down 0.1% Since Last Earnings Report? - Zacks Investment Research
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger – AUUD, TECH, CZR and CBAN - GlobeNewswire Inc.
Research Use Recombinant Protein Market Report Now Available — Forecasts Market Growth from $1.11B (2026) to $1.55B by 2031, Profiling Thermo Fisher, Bio-Techne, Merck KGaA, Danaher, Revvity, and Others - Yahoo Finance UK
Bio-Techne Corp (TECH) Stock Analysis: Navigating Its Current Valuation and Growth Potential - DirectorsTalk Interviews
Bio-Techne Corp (NASDAQ: TECH) Share Price, TECH Stock News, TECH Share Price & Updates - Kalkine
Ademi LLP investigates Bio-Techne sale to Merck KGaA - scanx.trade
Global Multiplex Assays Market 2026 Edition Consumables Dominate Multiplex Assays with 68% Market Share - GlobeNewswire Inc.
Bio-Techne (TECH), What Is Behind The Latest Attention? - simplywall.st
TECH: Bio-Techne Corp Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals - marketscreener.com
Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals - Stock Titan
Bio-Techne Corp (TECH) Stock Analysis: Evaluating the Balance Between Growth Potential and Current Valuation - DirectorsTalk Interviews
Winners And Losers Of Q2: Bio-Techne (NASDAQ:TECH) Vs The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance
Legal & General buys $19.51M stake in Bio-Techne - Dealroom
Bio-Techne Corp (TECH) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Bio-Techne To Be Acquired by Merck KGaA - Morningstar
BIO-TECHNE Corp FY 2026: Revenue $1.22B, EPS $1.16— 10-K Summary - TradingView
Bio-Techne draws fresh institutional cash as revenue climbs to $321M - app.dealroom.co
Bio-Techne Gives FTC More Time On $11.3B Merck Deal - Law360
Is Bio-Rad a Buy as Digital PCR Growth Meets a Premium Valuation? - TradingView
Bio-Techne (Nasdaq: TECH) investors to vote on Merck cash takeover - Stock Titan
Bio-Techne (NASDAQ: TECH) GC gets new RSU grants, no stock sales - Stock Titan
Bio-Techne (NASDAQ: TECH) grants CFO 22,438 and 36,459 RSUs - Stock Titan
Bio-Techne (TECH) director granted 1,381 RSUs vesting 2027-29 - Stock Titan
Bio-Techne (TECH) insider updates stock holdings - Stock Titan
4.81%
자본화:
|
볼륨(24시간):